Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire

Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire

Source: 
Forbes
snippet: 

Today’s listing at the Shanghai Stock Exchange by Sichuan Biokin Pharmaceutical, a supplier of cancer drugs, has minted China’s latest billionaire.

Chairman Zhu Yi directly owns 298.1 million shares, worth 10 billion yuan, or $1.5 billion in early afternoon trading. Shares rose 36% from their IPO price to 33.69 yuan.